Step-by-step recovery protocol for peptide brands whose Meta ad accounts have been banned: first 48 hours, formal appeal, prevention plan, and what to do if appeals fail.
.png)
Meta ads for peptide companies get banned faster than almost any other product category. Meta’s automated review is aggressive, the policy language is broad, and recovery from a ban is significantly harder on Meta than on Google.
This guide covers what to do when your peptide company’s Meta ads account is banned — and how to build a strategy that doesn’t depend on Meta staying open.
Meta classifies most peptides under its “unsafe supplements” or “prescription drugs” ad policies. The automated system flags compound names in copy, images that imply injection or dosing, and landing pages with therapeutic language. Human review rarely reverses automated flags for this category.
Many peptide brands can’t get Meta back — or decide the compliance overhead isn’t worth it. The alternative paid-media stack that produces comparable results:
If you want to keep Meta open going forward: no compound names in ad creative, outcome-adjacent copy only, retargeting-only strategy (no cold prospecting with peptide-specific copy), and product catalogue with clean descriptions.
See how we rebuilt a complete paid media stack after a Meta ban and reached $67K/month at 3.8x ROAS.
Book a free recovery consultation →
Working with a compliant paid media agency that understands the peptide space makes the difference between sustainable growth and a banned account. Get a free strategy session with Oney Studio.
Get a free 30-minute audit of your Google Ads or Meta Ads account. We’ll review compliance, structure, and growth opportunities — no strings attached.
Book a Free Audit